Introduction
Procalcitonin (PCT) increases its serum levels in bacterial infections and this justifies its introduction into clinical practice as a specific biomarker in inflammation. So far it has not been studied in the surgery of inflammatory diseases of the head and neck.
Materials and Methods
The study included 80 patients with head and neck abscesses over the age of 18 who were tested for C-reactive protein (CRP) and PCT. They were divided into two groups—50 (28 men and 22 women) with odontogenic and 30 (20 men and 10 women) with non-odontogenic abscesses.
The control group consisted of 51 age- and gender-matched healthy people.
CRP and PCT were determined by latex-enhanced immunoturbidimetric assay—CRP with COBAS 6000 biochemical analyzer and PCT with Advia 1800 biochemical analyzer (Siemens).
Results and Discussion
In the group with odontogenic abscesses, the average value of CRP was 104.94 ± 110.63 mg/L and that of PCT was 0.84 ± 1.01 ng/mL.
In the group with non-odontogenic abscesses, the mean value of CRP was 36.85 ± 5.34 mg/L and of PCT was 1.36 ± 1.55 ng/mL.
In the control group, the mean value of CRP was 0.806 ± 0.95 mg/L and that of PCT was 0.16 ± 0.13 ng/mL.
Significantly higher CRP values were observed in the group with odontogenic abscesses compared to the values of the same indicator in the group with non-odontogenic abscesses. At the same time, the PCT values were higher in the group with non-odontogenic abscesses compared to the same marker in the studied group with odontogenic abscesses.
Statistically significantly (p < 0.05) higher values of CRP and PCT were observed in the studied group with odontogenic abscesses compared to the same in the control group.
The values of CRP and PCT in the studied group with non-odontogenic abscesses were statistically significantly (p < 0.05) higher than the same marker in the control group.
Conclusion
According to the analysis of the obtained data we can conclude that PCT can be used as a potential laboratory marker in the diagnosis and treatment of patients with odontogenic and non-odontogenic abscesses of the head and neck. It corresponds equally well to CRP values in the clinical diagnosis of these nosological units.
Карастанева А, Бошева М. Място на прокалцитонина в диагнозата, мониторирането и провеждането на антибиотична терапия при бактериални инфекции в детската възраст, Наука пулмология. 2014. 1. 5-9.
Митева Д, Радков Й, Иванова Л, Червенков Т, Костадинова В. Роля на прокалцитонин в диагностиката и прогнозата на пневмония придобите в обществото. Торакална медицина. 2016 септември. 2. 38-47.
Мaruna P, Nedelníková K, Gürlich R., Physiology and genetics of procalcitonin. Physiol Res. 2000. 49 Suppl 1:S57-61.
Christ-Crain M, Müller B. Procalcitonin in bacterial infections--hype, hope, more or less? Swiss Med Wkly. 2005 Aug 6;135(31-32):451-60.
Cleland DA, Eranki AP. Procalcitonin. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539794/
Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002;323:17–29.
Linscheid P, Seboek D, Nylen ES, Langer I, Schlatter M, Becker KL, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: A novel product of human adipose tissue. Endocrinology. 2003 Dec 1;144(12):5578-84.
Meisner M. Procalcitonin-biochemistry and clinical diagnosis. Dresden (Germany): UNI-MED-Verlag; 2010.
Meisner M, Tschaikowsky K, Hutzler A, Schüttler J, Schick C. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998;24(7):680–4.
Chiesa C, Panero A, Rossi N, Stegagno M, Giusti MD, Osborn JF, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998 Mar 1;26(3):664-72.
Reith HB, Mittelkötter U, Debus ES, Küssner C, Thiede A. Procalcitonin in early detection of postoperative complications. Dig Surg. 1998;15(3):260-265.
Meisner M, Procalcitonin (PCT) Biochemical and clinical aspects. 3rd revised and extended edition 57 figures, 23 tables © 2000 Georg Thieme Verlag, Stuttgart ISBN:3-13-105503-0.
Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436–45.
Waheeda Nargis, Md Ibrahim, Borhan Uddin Ahamed. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Crit Illn Inj Sci. 2014 Jul-Sep; 4(3): 195–199. doi: 10.4103/2229-5151.14135
Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH (December 2016). "Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine" (PDF). Wisconsin Medical Journal (WMJ). 115 (6): 317–21.
Kao PC, Shiesh SC, Wu TJ. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci. 2006 Spring;36(2):163-9. PMID: 16682512.
Waheeda Nargis, Md Ibrahim, Borhan Uddin Ahamed. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014 Jul-Sep; 4(3): 195–199. doi: 10.4103/2229-5151.141356
Nishikawa H, Shirano M, Kasamatsu Y, Morimura A, Iida K, Kishi T, Goto T, Okamoto S, Ehara E. Comparison between procalcitonin and C-reactive protein in predicting bacteremias and confounding factors: a case-control study. Clin Chem Lab Med. 2017 Jun 27;55(7):1043-1052. doi: 10.1515/cclm-2016-0705. PMID: 27740914.
Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999;3(1):45-50. doi: 10.1186/cc306. PMID: 11056723; PMCID: PMC29013.
Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003 Jun;31(6):1737-41. doi: 10.1097/01.CCM.0000063440.19188.ED. PMID: 12794413.
Tanrıverdi H, Örnek T, Erboy F, Altınsoy B, Uygur F, Atalay F, Tor MM. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Wien Klin Wochenschr. 2015 Oct;127(19-20):756-63. doi: 10.1007/s00508-014-0690-6. Epub 2015 Jan 14. PMID: 25586444.
Morales Casado MI, Moreno Alonso F, Juárez Belaunde AL, Heredero Gálvez E, Talavera Encinas O, Julián-Jiménez A. Ability of procalcitonin to predict bacterial meningitis in the emergency department. Neurologia. 2016 Jan-Feb;31(1):9-17. English, Spanish. doi: 10.1016/j.nrl.2014.07.003. Epub 2014 Oct 5. PMID: 25288535.
Ibrahim KA, Abdel-Wahab AA, Ibrahim AS. Diagnostic value of serum procalcitonin levels in children with meningitis: a comparison with blood leukocyte count and C-reactive protein. J Pak Med Assoc. 2011 Apr;61(4):346-51. PMID: 21465970.
Zhinous Bayat-Makoo, Rezvaniye Salehi, Alireza Motallemi, Hadiseh Kavandi, Mohammad Naghavi-Behzad4, Ali-Asghar Moghani. Investigation of the role of procalcitonin in early diagnosis of infective endocarditis. J Anal Res Clin Med, 2018, 6(1), 28-33. doi: 10.15171/jarcm.2018.005, http://journals.tbzmed.ac.ir/JARCM
Meyer NJM. Finding a needle in the haystack: leveraging bioinformatics to identify a functional genetic risk factor for sepsis death,Crit Care Med 2015 Jan; 43(1):242-3. doi: 10.1097/CCM.0000000000000664
